+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cancer Diagnostics - Global Market Trajectory & Analytics

  • ID: 5141013
  • Report
  • September 2020
  • Region: Global
  • 308 pages
  • Global Industry Analysts, Inc
1 of 2
Global Cancer Diagnostics Market to Reach $223.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Cancer Diagnostics estimated at US$150.6 Billion in the year 2020, is projected to reach a revised size of US$223.3 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Laboratory Tests, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$50.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genetic Tests segment is readjusted to a revised 6.4% CAGR for the next 7-year period.

The U. S. Market is Estimated at $40.8 Billion, While China is Forecast to Grow at 8.8% CAGR

The Cancer Diagnostics market in the U. S. is estimated at US$40.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$46.7 Billion by the year 2027 trailing a CAGR of 8.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Imaging Segment to Record 6.2% CAGR

In the global Imaging segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$28.4 Billion in the year 2020 will reach a projected size of US$41.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$30.1 Billion by the year 2027, while Latin America will expand at a 7.4% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 308-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • Abbott Diagnostics
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambry Genetics Corporation
  • Applied Imaging
  • AstraZeneca PLC
  • AutoGenomics, Inc.
  • BARD, A Becton, Dickinson Company
  • Bayer AG
  • Becton, Dickinson and Company
  • BioCurex, Inc.
  • bioMeriux SA
  • Celara Diagnostics
  • Diagnostic Products Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Genoptix, Inc.
  • GlaxoSmithKline PLC
  • Hologic, Inc.
  • Illumina, Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • QIAGEN GmbH
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • Cancer Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Cancer Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Cancer Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Cancer Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Laboratory Tests (Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Laboratory Tests (Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Laboratory Tests (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Genetic Tests (Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Genetic Tests (Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Genetic Tests (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Imaging (Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Imaging (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Imaging (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Endoscopy (Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Endoscopy (Type) Market Historic Review by Region/Country in US$ Million:2012 to 2019
  • TABLE 15: Endoscopy (Type) Market Share Breakdown by Region/Country:2012 VS 2020 VS 2027
  • TABLE 16: Biopsy (Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 17: Biopsy (Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 18: Biopsy (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Other Types (Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
  • TABLE 20: Other Types (Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 21: Other Types (Type) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 22: Breast (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 23: Breast (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 24: Breast (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Lung (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 26: Lung (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
  • TABLE 27: Lung (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
  • TABLE 28: Colorectal (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 29: Colorectal (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 30: Colorectal (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 31: Skin (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2020-2027
  • TABLE 32: Skin (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 33: Skin (Application) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 34: Prostate (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 35: Prostate (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 36: Prostate (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 37: Blood (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 38: Blood (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
  • TABLE 39: Blood (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 40: Ovarian (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 41: Ovarian (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 42: Ovarian (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 43: Other Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 44: Other Applications (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
  • TABLE 45: Other Applications (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Cancer Diagnostics Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 46: United States Cancer Diagnostics Market Estimates and Projections in US$ Million by Type: 2020 to 2027
  • TABLE 47: Cancer Diagnostics Market in the United States by Type: A Historic Review in US$ Million for 2012-2019
  • TABLE 48: United States Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 49: United States Cancer Diagnostics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 50: Cancer Diagnostics Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
  • TABLE 51: Cancer Diagnostics Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
CANADA
  • TABLE 52: Canadian Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027
  • TABLE 53: Canadian Cancer Diagnostics Historic Market Review by Type in US$ Million: 2012-2019
  • TABLE 54: Cancer Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
  • TABLE 55: Canadian Cancer Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 56: Cancer Diagnostics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 57: Canadian Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
JAPAN
  • TABLE 58: Japanese Market for Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027
  • TABLE 59: Cancer Diagnostics Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019
  • TABLE 60: Japanese Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
  • TABLE 61: Japanese Demand Estimates and Forecasts for Cancer Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 62: Japanese Cancer Diagnostics Market in US$ Million by Application: 2012-2019
  • TABLE 63: Cancer Diagnostics Market Share Shift in Japan by Application: 2012 VS 2020 VS 2027
CHINA
  • TABLE 64: Chinese Cancer Diagnostics Market Growth Prospects in US$ Million by Type for the Period 2020-2027
  • TABLE 65: Cancer Diagnostics Historic Market Analysis in China in US$ Million by Type: 2012-2019
  • TABLE 66: Chinese Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 67: Chinese Demand for Cancer Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 68: Cancer Diagnostics Market Review in China in US$ Million by Application: 2012-2019
  • TABLE 69: Chinese Cancer Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
EUROPE
  • Market Facts & Figures
  • European Cancer Diagnostics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 70: European Cancer Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
  • TABLE 71: Cancer Diagnostics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 72: European Cancer Diagnostics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 73: European Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020-2027
  • TABLE 74: Cancer Diagnostics Market in Europe in US$ Million by Type: A Historic Review for the Period 2012-2019
  • TABLE 75: European Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 76: European Cancer Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 77: Cancer Diagnostics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 78: European Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
FRANCE
  • TABLE 79: Cancer Diagnostics Market in France by Type: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 80: French Cancer Diagnostics Historic Market Scenario in US$ Million by Type: 2012-2019
  • TABLE 81: French Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
  • TABLE 82: Cancer Diagnostics Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
  • TABLE 83: French Cancer Diagnostics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 84: French Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
GERMANY
  • TABLE 85: Cancer Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
  • TABLE 86: German Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019
  • TABLE 87: German Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 88: Cancer Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 89: German Cancer Diagnostics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 90: Cancer Diagnostics Market Share Distribution in Germany by Application: 2012 VS 2020 VS 2027
ITALY
  • TABLE 91: Italian Cancer Diagnostics Market Growth Prospects in US$ Million by Type for the Period 2020-2027
  • TABLE 92: Cancer Diagnostics Historic Market Analysis in Italy in US$ Million by Type: 2012-2019
  • TABLE 93: Italian Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 94: Italian Demand for Cancer Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 95: Cancer Diagnostics Market Review in Italy in US$ Million by Application: 2012-2019
  • TABLE 96: Italian Cancer Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED KINGDOM
  • TABLE 97: United Kingdom Market for Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027
  • TABLE 98: Cancer Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019
  • TABLE 99: United Kingdom Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
  • TABLE 100: United Kingdom Demand Estimates and Forecasts for Cancer Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 101: United Kingdom Cancer Diagnostics Market in US$ Million by Application: 2012-2019
  • TABLE 102: Cancer Diagnostics Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS 2027
SPAIN
  • TABLE 103: Spanish Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027
  • TABLE 104: Spanish Cancer Diagnostics Historic Market Review by Type in US$ Million: 2012-2019
  • TABLE 105: Cancer Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
  • TABLE 106: Spanish Cancer Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 107: Cancer Diagnostics Market in Spain: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 108: Spanish Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
RUSSIA
  • TABLE 109: Russian Cancer Diagnostics Market Estimates and Projections in US$ Million by Type: 2020 to 2027
  • TABLE 110: Cancer Diagnostics Market in Russia by Type: A Historic Review in US$ Million for 2012-2019
  • TABLE 111: Russian Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 112: Russian Cancer Diagnostics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 113: Cancer Diagnostics Historic Demand Patterns in Russia by Application in US$ Million for 2012-2019
  • TABLE 114: Cancer Diagnostics Market Share Breakdown in Russia by Application: 2012 VS 2020 VS 2027
REST OF EUROPE
  • TABLE 115: Rest of Europe Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020-2027
  • TABLE 116: Cancer Diagnostics Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2012-2019
  • TABLE 117: Rest of Europe Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 118: Rest of Europe Cancer Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 119: Cancer Diagnostics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 120: Rest of Europe Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
ASIA-PACIFIC
  • TABLE 121: Asia-Pacific Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 122: Cancer Diagnostics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 123: Asia-Pacific Cancer Diagnostics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 124: Cancer Diagnostics Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 125: Asia-Pacific Cancer Diagnostics Historic Market Scenario in US$ Million by Type: 2012-2019
  • TABLE 126: Asia-Pacific Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
  • TABLE 127: Cancer Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
  • TABLE 128: Asia-Pacific Cancer Diagnostics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 129: Asia-Pacific Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
AUSTRALIA
  • TABLE 130: Cancer Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
  • TABLE 131: Australian Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019
  • TABLE 132: Australian Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 133: Cancer Diagnostics Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 134: Australian Cancer Diagnostics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 135: Cancer Diagnostics Market Share Distribution in Australia by Application: 2012 VS 2020 VS 2027
INDIA
  • TABLE 136: Indian Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027
  • TABLE 137: Indian Cancer Diagnostics Historic Market Review by Type in US$ Million:2012-2019
  • TABLE 138: Cancer Diagnostics Market in India: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
  • TABLE 139: Indian Cancer Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 140: Cancer Diagnostics Market in India: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 141: Indian Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
SOUTH KOREA
  • TABLE 142: Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
  • TABLE 143: South Korean Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019
  • TABLE 144: Cancer Diagnostics Market Share Distribution in South Korea by Type: 2012 VS 2020 VS 2027
  • TABLE 145: Cancer Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
  • TABLE 146: South Korean Cancer Diagnostics Historic Market Analysis in US$ Million by Application: 2012-2019
  • TABLE 147: Cancer Diagnostics Market Share Distribution in South Korea by Application: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
  • TABLE 148: Rest of Asia-Pacific Market for Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027
  • TABLE 149: Cancer Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019
  • TABLE 150: Rest of Asia-Pacific Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
  • TABLE 151: Rest of Asia-Pacific Demand Estimates and Forecasts for Cancer Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 152: Rest of Asia-Pacific Cancer Diagnostics Market in US$ Million by Application: 2012-2019
  • TABLE 153: Cancer Diagnostics Market Share Shift in Rest of Asia-Pacific by Application: 2012 VS 2020 VS 2027
LATIN AMERICA
  • TABLE 154: Latin American Cancer Diagnostics Market Trends by Region/Country in US$ Million: 2020-2027
  • TABLE 155: Cancer Diagnostics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
  • TABLE 156: Latin American Cancer Diagnostics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
  • TABLE 157: Latin American Cancer Diagnostics Market Growth Prospects in US$ Million by Type for the Period 2020-2027
  • TABLE 158: Cancer Diagnostics Historic Market Analysis in Latin America in US$ Million by Type: 2012-2019
  • TABLE 159: Latin American Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 160: Latin American Demand for Cancer Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 161: Cancer Diagnostics Market Review in Latin America in US$ Million by Application: 2012-2019
  • TABLE 162: Latin American Cancer Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
ARGENTINA
  • TABLE 163: Argentinean Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020-2027
  • TABLE 164: Cancer Diagnostics Market in Argentina in US$ Million by Type: A Historic Review for the Period 2012-2019
  • TABLE 165: Argentinean Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 166: Argentinean Cancer Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 167: Cancer Diagnostics Market in Argentina: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 168: Argentinean Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
BRAZIL
  • TABLE 169: Cancer Diagnostics Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 170: Brazilian Cancer Diagnostics Historic Market Scenario in US$ Million by Type: 2012-2019
  • TABLE 171: Brazilian Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
  • TABLE 172: Cancer Diagnostics Quantitative Demand Analysis in Brazil in US$ Million by Application: 2020-2027
  • TABLE 173: Brazilian Cancer Diagnostics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 174: Brazilian Cancer Diagnostics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
MEXICO
  • TABLE 175: Cancer Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
  • TABLE 176: Mexican Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019
  • TABLE 177: Mexican Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 178: Cancer Diagnostics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 179: Mexican Cancer Diagnostics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 180: Cancer Diagnostics Market Share Distribution in Mexico by Application: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
  • TABLE 181: Rest of Latin America Cancer Diagnostics Market Estimates and Projections in US$ Million by Type: 2020 to 2027
  • TABLE 182: Cancer Diagnostics Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2012-2019
  • TABLE 183: Rest of Latin America Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 184: Rest of Latin America Cancer Diagnostics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 185: Cancer Diagnostics Historic Demand Patterns in Rest of Latin America by Application in US$ Million for 2012-2019
  • TABLE 186: Cancer Diagnostics Market Share Breakdown in Rest of Latin America by Application: 2012 VS 2020 VS 2027
MIDDLE EAST
  • TABLE 187: The Middle East Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 188: Cancer Diagnostics Market in the Middle East by Region/Country in US$ Million: 2012-2019
  • TABLE 189: The Middle East Cancer Diagnostics Market Share Breakdown by Region/Country: 2012, 2020, and 2027
  • TABLE 190: The Middle East Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020 to 2027
  • TABLE 191: The Middle East Cancer Diagnostics Historic Market by Type in US$ Million: 2012-2019
  • TABLE 192: Cancer Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2012,2020, and 2027
  • TABLE 193: The Middle East Cancer Diagnostics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 194: Cancer Diagnostics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 195: The Middle East Cancer Diagnostics Market Share Analysis by Application: 2012 VS 2020 VS 2027
IRAN
  • TABLE 196: Iranian Market for Cancer Diagnostics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2020-2027
  • TABLE 197: Cancer Diagnostics Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2012-2019
  • TABLE 198: Iranian Cancer Diagnostics Market Share Analysis by Type: 2012 VS 2020 VS 2027
  • TABLE 199: Iranian Demand Estimates and Forecasts for Cancer Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 200: Iranian Cancer Diagnostics Market in US$ Million by Application: 2012-2019
  • TABLE 201: Cancer Diagnostics Market Share Shift in Iran by Application: 2012 VS 2020 VS 2027
ISRAEL
  • TABLE 202: Israeli Cancer Diagnostics Market Estimates and Forecasts in US$ Million by Type: 2020-2027
  • TABLE 203: Cancer Diagnostics Market in Israel in US$ Million by Type: A Historic Review for the Period 2012-2019
  • TABLE 204: Israeli Cancer Diagnostics Market Share Breakdown by Type:2012 VS 2020 VS 2027
  • TABLE 205: Israeli Cancer Diagnostics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 206: Cancer Diagnostics Market in Israel: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 207: Israeli Cancer Diagnostics Market Share Analysis by Application:2012 VS 2020 VS 2027
SAUDI ARABIA
  • TABLE 208: Saudi Arabian Cancer Diagnostics Market Growth Prospects in US$ Million by Type for the Period 2020-2027
  • TABLE 209: Cancer Diagnostics Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2012-2019
  • TABLE 210: Saudi Arabian Cancer Diagnostics Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 211: Saudi Arabian Demand for Cancer Diagnostics in US$ Million by Application: 2020 to 2027
  • TABLE 212: Cancer Diagnostics Market Review in Saudi Arabia in US$ Million by Application: 2012-2019
  • TABLE 213: Saudi Arabian Cancer Diagnostics Market Share Breakdown by Application: 2012 VS 2020 VS 2027
UNITED ARAB EMIRATES
  • TABLE 214: Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
  • TABLE 215: United Arab Emirates Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019
  • TABLE 216: Cancer Diagnostics Market Share Distribution in United Arab Emirates by Type: 2012 VS 2020 VS 2027
  • TABLE 217: Cancer Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Application for the Period 2020-2027
  • TABLE 218: United Arab Emirates Cancer Diagnostics Historic Market Analysis in US$ Million by Application: 2012-2019
  • TABLE 219: Cancer Diagnostics Market Share Distribution in United Arab Emirates by Application: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
  • TABLE 220: Cancer Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2020-2027
  • TABLE 221: Rest of Middle East Cancer Diagnostics Historic Market Analysis in US$ Million by Type: 2012-2019
  • TABLE 222: Rest of Middle East Cancer Diagnostics Market Share Breakdown by Type: 2012 VS 2020 VS 2027
  • TABLE 223: Cancer Diagnostics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 224: Rest of Middle East Cancer Diagnostics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 225: Cancer Diagnostics Market Share Distribution in Rest of Middle East by Application: 2012 VS 2020 VS 2027
AFRICA
  • TABLE 226: African Cancer Diagnostics Market Estimates and Projections in US$ Million by Type: 2020 to 2027
  • TABLE 227: Cancer Diagnostics Market in Africa by Type: A Historic Review in US$ Million for 2012-2019
  • TABLE 228: African Cancer Diagnostics Market Share Breakdown by Type:2012 VS 2020 VS 2027
  • TABLE 229: African Cancer Diagnostics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 230: Cancer Diagnostics Historic Demand Patterns in Africa by Application in US$ Million for 2012-2019
  • TABLE 231: Cancer Diagnostics Market Share Breakdown in Africa by Application: 2012 VS 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 47
Note: Product cover images may vary from those shown
Adroll
adroll